Artelo Biosciences, Inc. (ARTL) vs CDT Equity Inc. (CDT)
A side-by-side comparison of Artelo Biosciences, Inc. and CDT Equity Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARTL
Artelo Biosciences, Inc.
$3.63HealthcareDelayed quote: Oct 6, 2026, 10:34 AM EDT
CDT
CDT Equity Inc.
$0.88HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
Total return — ARTL vs CDT
growth of $100 · dividends reinvested · last 3yARTL -95.2% (-63.6%/yr)CDT -100.0% (-99.8%/yr)ARTL compounded faster over this window
Log scale — wide-divergence pair
ARTL CDT
ARTL vs CDT: by the numbers
- •ARTL is the larger company ($1M vs $681478 market cap).
- •CDT is profitable (6.30% net margin) while ARTL runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ARTL | CDT |
|---|---|---|
| P/S ratio | N/A | 0.00 |
| P/B ratio | 0.28 | 0.00 |
| EV / EBITDA | N/A | 4.13 |
Profitability
| Metric | ARTL | CDT |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 6.30% |
| ROE | -253.57% | 6.58% |
| ROIC | -219.36% | 4.47% |
Growth (annualized)
| Metric | ARTL | CDT |
|---|---|---|
| Total return CAGR (5Y) | -64.27% | N/A |
Frequently asked
- Is ARTL or CDT more profitable?
- CDT runs the higher net margin — ARTL at 0.00% versus CDT at 6.30%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.